Disclosed are sulfonamide compounds of Formula (I): or stereoisomers, N-oxides, prodrugs, or pharmaceutically acceptable salts thereof, wherein ring A, R
1
, R
2
, R
3
, R
4
and R
5
are defined herein. Also disclosed are methods of using such compounds in the treatment of conditions related to CYP17 enzyme, such as cancer, and pharmaceutical compositions comprising such compounds.
本发明涉及式(I)的磺
酰胺化合物,或其立体异构体、N-
氧化物、前药或其药学上可接受的盐,其中环A、R1、R2、R3、R4和R5如本文所定义。同时,本发明还涉及使用这些化合物治疗与CYP17酶有关的疾病,如癌症,以及包含这些化合物的药物组合物的方法。